Vari-Gone
Vari-Gone, licence 80074742: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nature's Sunshine Products of Canada Ltd.
- NPN or DIN-HM
- 80074742
- Status
- Active licence
- Licence date
- 3 January 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Styphnolobium japonicum - Bourgeon floral | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus aurantium - fruit | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus reticulata - Fruit | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus sinensis - fruit | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus paradisi - Fruit | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus limon - Fruit | 30.0 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Bioflavonoïdes d'agrumes | 30.0 milligramme | Not calculated |
| Ruscus aculeatus Source : Racine | 175.0 milligramme | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) | 45.0 milligramme | Not calculated |
| Aesculus hippocastanum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 700 milligramme Potency : 20.0 % Aescin | 175.0 milligramme | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus limon - Pelure (fruit) | 30.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help treat chronic venous insufficiency and associated symptoms. Used in Herbal Medicine to help treat varicose veins. An antioxidant for the maintenance of good health. Horse chestnut/Aescuslus hippocastanum is traditionally used in Herbal Medicine to help treat haemorrhoids.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience headache, dizziness, gastric irritation, or itchiness. Hypersensitivity, such as an allergy, has been known to occur in rare cases; in which, discontinue use. Diarrhea and rectal bleeding has been known to occur; in which case, discontinue use. If you suffer from gastrointestinal disorders such as irritation, ulcer, gastric reflux, Celiac disease, etc., consult health care practitioner prior to use. If inflammation of the skin or subcutaneous induration, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency, occurs discontinue use and consult a health car practitioner. Consult a health care practitioner prior to use if are taking any prescription medications.
- Précautions et mises en garde
Consult a health care practitioner is symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80074742
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.